The OPEN MINDS Executive Blueprint For Crisis Management: Building Organizational Sustainability & Success In A Disrupted Health & Human Service Market
A 32-week program designed to help executive teams navigate the business, organizational, operational, and culture changes of a market in turbulence. The program, based on the seven-component OPEN MINDS Executive Blueprint, combines a series of 35 live web briefings with online technical assistance and a suite of on-demand resources.
Diabetes Medicine Glitazone Linked To 35% Lower Risk Of Parkinson´s Disease
People with Type 2 diabetes who took the antidiabetes drug glitazone to decrease blood glucose levels and preserve the pancreas’ ability to produce insulin also had a reduced risk of developing Parkinson’s disease. Over a 10-year period, those who took glitazone had a 35% lower risk of developing Parkinson’s disease. Parkinson’s disease is a neurodegenerative disorder that affects about 2% of people age 65 and older. The prevalence increases with age.
These findings were reported in “Glitazone Use Associated With Reduced Risk Of Parkinson's Disease” by Brage Brakedal, BA, M.D.; Irene Flønes, M . . .